跳至主要内容
临床试验/NCT04213729
NCT04213729已完成不适用

A Holistic Diet Intervention for People With Crohn's Disease

University of Miami2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年11月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
2
主要终点
Rate of adherence to fat intake

研究概览

简要总结

The purpose of this study is to determine the effectiveness of a low-fat, high fiber diet (LFD) containing a minimal proportion of fat to improve gastrointestinal symptoms, quality of life and signs of inflammation in blood and stool.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Rate of adherence to fat intake

时间窗: Week 36

Adherence to fat intake is measured by the web-based Automated Self-Administered 24-hour diet recall (ASA24).

Change in fat intake

时间窗: Baseline, 8 weeks

Change in daily fat intake calculated through patient reported diet diary app Nutrihand.

次要结局

  • Change in clinical symptoms as assessed by Patient Reported Outcomes (PRO2).(Baseline, Week 8)
  • Change in quality of life (QoL) as assessed by the Short Inflammation Bowel Disease Questionnaire (sIBDQ).(Baseline, Week 8)
  • Change in clinical symptoms as assessed by the Short Crohn's Disease Activity Index (sCDAI).(Baseline, Week 8)
  • Change in clinical symptoms as assessed by the Harvey Bradshaw Index (HBI)(Baseline, Week 8)
  • Change in the expression of cytokine high-sensitivity C-reactive protein (hsCRP).(Baseline, Week 8)
  • Change in quality of life (QoL) as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS-29).(Baseline, Week 8)
  • Change in the expression of Serum Amyloid A (SAA).(Baseline, Week 8)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Abreu

Professor of Medicine

University of Miami

研究点 (2)

Loading locations...

相似试验

Diet Intervention for Crohn's Disease Patient | 临床试验